Streetbeat News

Equity Actions

AZTR

Azitra, Inc. (NYSE:AZTR), a clinical-stage biopharmaceutical company, has appointed Travis Whitfill as its Chief Operating Officer. Whitfill is a co-founder of Azitra and was previously a partner at Bios Partners. He has served on Azitra's board of directors since 2014 and has a strong background in biotech, synthetic biology, and drug development.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 8:09 pm

JUPW

Jupiter Wellness has announced the postponement of the spin-off and distribution of common stock of its subsidiary, SRM Entertainment. The company intends to proceed with the distribution as soon as it complies with federal securities laws and receives regulatory approval.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 8:06 pm

EH

EHang, a leading autonomous aerial vehicle (AAV) technology platform company, has announced a $23 million private placement led by investor Lee Soo Man. The funds will be used to further develop EHang's technology and expand its market presence.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 8:01 pm

COIN

Coinbase has reached a surveillance-sharing agreement for five of its spot bitcoin ETF applications, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 7:48 pm

HVT

Benchmark analyst Michael Legg initiated coverage on Haverty Furniture Companies Inc (HVT) with a Buy rating and a price target of $41. The analyst believes that HVT's strong sales during COVID, improved margins due to internal initiatives, positive migration trends in key states, and a debt-free balance sheet with significant free cash flow make it an attractive investment. The company's stock is currently trading higher by 3.9% at $31.94.

Portfolio Pulse from Shivani Kumaresan

July 11, 2023 | 7:37 pm

MMM

A significant investor has taken a bullish stance on 3M (NYSE:MMM), with 60% of the investors opening trades with bullish expectations and 40% with bearish. The investor has been targeting a price range from $100.0 to $115.0 for 3M over the last 3 months. The price of MMM is up 4.32% at $101.39. Morgan Stanley, Wells Fargo, Barclays, Citigroup, and DA Davidson have maintained their ratings on 3M.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 7:32 pm

MPC

A significant bearish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 90% bearish and 10% bullish. The whales have been targeting a price range from $110.0 to $130.0 for Marathon Petroleum over the last 3 months. Wells Fargo and Barclays have maintained their Equal-Weight and Overweight ratings on Marathon Petroleum, respectively, with price targets of $120 and $132.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 7:32 pm

DRUG

Bright Minds Biosciences Inc. (NASDAQ:DRUG) is planning a 5:1 consolidation of its common shares to increase its attractiveness to investors and regain compliance with NASDAQ’s minimum bid price requirement. The company currently has 18,860,359 common shares issued and outstanding, which will be reduced to approximately 3,772,071 total common shares post-consolidation. The consolidated shares are expected to begin trading on July 14.

Portfolio Pulse from Lara Goldstein

July 11, 2023 | 7:25 pm

CMG

A significant number of investors have taken a bearish stance on Chipotle Mexican Grill (NYSE:CMG), with 75% of detected trades being bearish. The targeted price range for CMG over the last 3 months is $1320.0 to $2200.0. The current price of CMG is down -1.8% at $2055.43. Analysts from Raymond James, Keybanc, and Wedbush maintain an Outperform rating with a price target of $2300, while TD Cowen and Piper Sandler have downgraded their ratings.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 7:17 pm

ISRG

A significant investor has taken a bullish stance on Intuitive Surgical (NASDAQ:ISRG), with 60% of recent trades being bullish and 40% bearish. The total amount for puts is $188,205 and for calls is $282,504. Whales have been targeting a price range from $200.0 to $360.0 for Intuitive Surgical over the last 3 months. Citigroup maintains their Buy rating on Intuitive Surgical with a price target of $400.

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 7:02 pm